These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28710848)

  • 1. Breaking Transmission with Vaccines: The Case of Tuberculosis.
    Gonzalo-Asensio J; Aguilo N; Marinova D; Martin C
    Microbiol Spectr; 2017 Jul; 5(4):. PubMed ID: 28710848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomics of the Mycobacterium signaling architecture and implications for a novel live attenuated Tuberculosis vaccine.
    Zhou P; Xie J
    Hum Vaccin Immunother; 2014; 10(1):159-63. PubMed ID: 24013364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Mycobacterium bovis and Mycobacterium tuberculosis in animals: Transmission dynamics and control challenges of zoonotic TB in Ethiopia.
    Romha G; Gebru G; Asefa A; Mamo G
    Prev Vet Med; 2018 Oct; 158():1-17. PubMed ID: 30220382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad diversity of Mycobacterium tuberculosis complex strains isolated from humans and cattle in Northern Algeria suggests a zoonotic transmission cycle.
    Damene H; Tahir D; Diels M; Berber A; Sahraoui N; Rigouts L
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008894. PubMed ID: 33253150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
    Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
    EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of Mycobacterium bovis subsp. bovis among the strains of Mycobacterium tuberculosis complex isolated in Düzce Province, Turkey].
    Öztürk CE; Şahin İ; Öksüz Ş; Kılıç N; Kılınçel Ö; Aydın L; Atik D; Afşin E
    Mikrobiyol Bul; 2016 Jul; 50(3):392-400. PubMed ID: 27525395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA vaccine encoding MPB83 from Mycobacterium bovis reduces M. bovis dissemination to the kidneys of mice and is expressed in primary cell cultures of the European badger (Meles meles).
    Chambers MA; Stagg D; Gavier-Widén D; Lowrie D; Newell D; Hewinson RG
    Res Vet Sci; 2001 Oct; 71(2):119-26. PubMed ID: 11883890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges and opportunities for bacillus Calmette-Guérin replacement vaccine candidates.
    Méndez-Samperio P
    Scand J Immunol; 2019 Oct; 90(4):e12772. PubMed ID: 31055842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis Vaccine Development: Progress in Clinical Evaluation.
    Sable SB; Posey JE; Scriba TJ
    Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31666281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Mycobacterium bovis infection in the United Kingdom: Incidence, risks, control measures and review of the zoonotic aspects of bovine tuberculosis.
    de la Rua-Domenech R
    Tuberculosis (Edinb); 2006 Mar; 86(2):77-109. PubMed ID: 16257579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of tuberculosis vaccines in clinical trials: Current status.
    Méndez-Samperio P
    Scand J Immunol; 2018 Oct; 88(4):e12710. PubMed ID: 30175850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of Mycobacterium bovis infections in animals and man: a review.
    O'Reilly LM; Daborn CJ
    Tuber Lung Dis; 1995 Aug; 76 Suppl 1():1-46. PubMed ID: 7579326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
    Delogu G; Provvedi R; Sali M; Manganelli R
    Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Mycobacterium bovis persist in cattle in a non-replicative latent state as Mycobacterium tuberculosis in human beings?
    Sabio Y García J; Bigi MM; Klepp LI; García EA; Blanco FC; Bigi F
    Vet Microbiol; 2020 Aug; 247():108758. PubMed ID: 32768211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant live vaccine candidates against tuberculosis.
    Kaufmann SH; Gengenbacher M
    Curr Opin Biotechnol; 2012 Dec; 23(6):900-7. PubMed ID: 22483201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis.
    Roy A; Tomé I; Romero B; Lorente-Leal V; Infantes-Lorenzo JA; Domínguez M; Martín C; Aguiló N; Puentes E; Rodríguez E; de Juan L; Risalde MA; Gortázar C; Domínguez L; Bezos J
    Vet Res; 2019 Oct; 50(1):82. PubMed ID: 31615555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.